The Combination of Hand Grip Strength and Modified Glasgow Prognostic Score Predicts Clinical Outcomes in Patients with Liver Cancer
Yue Chen,Guo-Tian Ruan,Jin-Yu Shi,Tong Liu,Chen-An Liu,Hai-Lun Xie,Meng-Meng Song,Zi-Wen Wang,Chun-Lei Hu,He-Yang Zhang,Xiao-Wei Zhang,Hai-Ying Tian,Yi-Zhong Ge,Ming Yang,Yu-Ying Liu,Shi-Qi Lin,Xiao-Yue Liu,Xin Zheng,Kun-Hua Wang,Ming-Hua Cong,Xian Shen,Xin Wang,Li Deng,Han-Ping Shi
DOI: https://doi.org/10.3389/fnut.2023.1062117
IF: 5
2023-01-01
Frontiers in Nutrition
Abstract:PurposePrevious studies have shown that both hand grip strength (HGS) and the modified Glasgow Prognostic Score (mGPS) are associated with poor clinical outcomes in patients with liver cancer. In spite of this, no relevant studies have been conducted to determine whether the combination of HGS and mGPS can predict the prognosis of patients with liver cancer. Accordingly, this study sought to explore this possibility.MethodsThis was a multicenter study of patients with liver cancer. Based on the optimal HGS cutoff value for each sex, we determined the HGS cutoff values. The patients were divided into high and low HGS groups based on their HGS scores. An mGPS of 0 was defined as low mGPS, whereas scores higher than 0 were defined as high mGPS. The patients were combined into HGS-mGPS groups for the prediction of survival. Survival analysis was performed using Kaplan–Meier curves. A Cox regression model was designed and adjusted for confounders. To evaluate the nomogram model, receiver operating characteristic curves and calibration curves were used.ResultsA total of 504 patients were enrolled in this study. Of these, 386 (76.6%) were men (mean [SD] age, 56.63 [12.06] years). Multivariate analysis revealed that patients with low HGS and high mGPS had a higher risk of death than those with neither low HGS nor high mGPS (hazard ratio [HR],1.50; 95% confidence interval [CI],1.14–1.98; p = 0.001 and HR, 1.55; 95% CI, 1.14–2.12, p = 0.001 respectively). Patients with both low HGS and high mGPS had 2.35-fold increased risk of death (HR, 2.35; 95% CI, 1.52–3.63; p < 0.001). The area under the curve of HGS-mGPS was 0.623. The calibration curve demonstrated the validity of the HGS-mGPS nomogram model for predicting the survival of patients with liver cancer.ConclusionA combination of low HGS and high mGPS is associated with poor prognosis in patients with liver cancer. The combination of HGS and mGPS can predict the prognosis of liver cancer more accurately than HGS or mGPS alone. The nomogram model developed in this study can effectively predict the survival outcomes of liver cancer.